The VEGF Family Ligand-Receptor Interactions pathway (−log(p-value) = 2; Z-score = 1.41) is likely activated in the TME and contains 20 DEGs, 14 and 6 of which display higher expression in the TME and HCC tumors, respectively (Figure 6). This evidence concerns the gene VEGFA and hepatocellular carcinoma.